236 related articles for article (PubMed ID: 445497)
1. Phase II study of 5-fluorouracil, methyl-CCNU, and daunorubicin in colorectal cancer: a Cancer and Leukemia Group B study.
White LA; Perry MC; Kardinal CG; Kennedy BJ; Weiss RB; Carey RW
Cancer Treat Rep; 1979 Feb; 63(2):215-7. PubMed ID: 445497
[TBL] [Abstract][Full Text] [Related]
2. Methyl-CCNU versus methyl-CCNU and 5-fluorouracil in carcinoma of the large bowel.
Posey LE; Morgan LR
Cancer Treat Rep; 1977 Nov; 61(8):1453-8. PubMed ID: 922750
[TBL] [Abstract][Full Text] [Related]
3. Baker's antifol in combination with 5-fluorouracil and methyl-CCNU in the treatment of metastatic colorectal cancer: a Southwest Oncology Group Study (Protocol 7764).
Shaw MT; Bonnet JD; Wilson H; Heilbrun LK
Cancer Treat Rep; 1980; 64(2-3):247-50. PubMed ID: 7407758
[TBL] [Abstract][Full Text] [Related]
4. Treatment of advanced colorectal cancer with methyl-CCNU plus 5-day 5-fluorouracil infusion.
Kane RC; Cashdollar MR; Bernath AM
Cancer Treat Rep; 1978 Oct; 62(10):1521-5. PubMed ID: 709554
[TBL] [Abstract][Full Text] [Related]
5. Combination with 5-fluorouracil, methyl-CCNU and beta-2-deoxythioguanosine in advanced colo-rectal adenocarcinoma.
Cedermark BJ; Kaufman JH; Douglass HO; Mittelman A
Clin Oncol; 1977 Mar; 3(1):27-31. PubMed ID: 862274
[No Abstract] [Full Text] [Related]
6. Phase II trial of ftorafur with mitomycin C versus ftorafur with methyl-CCNU in untreated colorectal cancer.
Buroker T; Wojtaszak B; Dindogru A; DeMattia M; Baker L; Groth C; Vaitkevicius VK
Cancer Treat Rep; 1978 May; 62(5):689-92. PubMed ID: 350398
[TBL] [Abstract][Full Text] [Related]
7. [A clinical study (phase II) of a combination of 5-fluorouracil, vincristine and methyl CCNU in patients with advanced carcinoma of the large intestine].
Roth A; Kolarić K
Lijec Vjesn; 1983 Jun; 105(6):244-6. PubMed ID: 6633141
[No Abstract] [Full Text] [Related]
8. Phase I-II study of ftorafur and methyl-CCNU in advanced colorectal cancer.
Belt RJ; Stephens R
Cancer; 1979 Sep; 44(3):869-72. PubMed ID: 383275
[TBL] [Abstract][Full Text] [Related]
9. Methyl-CCNU (NSC-95441) in advanced colorectal carcinoma after failure of 5-fluorouracil (NSC-19893) therapy.
Cedermark BJ; Didolkar MS; Elias EG
Cancer Treat Rep; 1976 Mar; 60(3):235-8. PubMed ID: 769977
[TBL] [Abstract][Full Text] [Related]
10. [The combination methyl-CCNU, vincristine, 5-fluorouracil and streptozotocin in the treatment of advanced colo-rectal adenocarcinoma].
Togni P; Sessa C; Varini M; Cavalli F
Schweiz Med Wochenschr; 1982 Jun; 112(26):930-3. PubMed ID: 6214002
[TBL] [Abstract][Full Text] [Related]
11. 5-Fluorouracil (5-FU), methyl-CCNU, and vincristine in the treatment of advanced colorectal cancer: phase II study utilizing weekly 5-FU.
Macdonald JS; Kisner DF; Smythe T; Woolley PV; Smith L; Schein PS
Cancer Treat Rep; 1976 Nov; 60(11):1597-600. PubMed ID: 1021233
[TBL] [Abstract][Full Text] [Related]
12. Phase II evaluation of diglycoaldehyde, VP-16-213, and the combination of methyl-CCNU and beta-2'-deoxythioguanosine in previously treated patients with colorectal cancer: an Eastern Cooperative Oncology Group study (EST-1275).
Douglass HO; Lavin PT; Evans JT; Mittelman A; Carbone PP
Cancer Treat Rep; 1979 Aug; 63(8):1355-7. PubMed ID: 476709
[TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy in patients with advanced colorectal carcinoma previously treated with 5-FU.
Windschitl HE; Krook JE; Everson LK; Cullinan SA; Scott M
Cancer Treat Rep; 1982 Dec; 66(12):2093-4. PubMed ID: 7139652
[No Abstract] [Full Text] [Related]
14. Phase II study of melphalan in colorectal carcinoma.
DiBenedetto J; Moayeri H; Evans JT; Mittelman A
Cancer Treat Rep; 1978 Sep; 62(9):1401-2. PubMed ID: 688286
[TBL] [Abstract][Full Text] [Related]
15. Combination chemotherapy for advanced colorectal cancer with triazinate, ICRF-159, 5-FU, and methyl-CCNU.
Vogl SE; Qazi R; Berenzweig M
Cancer Treat Rep; 1980; 64(10-11):1143-5. PubMed ID: 7459902
[TBL] [Abstract][Full Text] [Related]
16. Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancer.
Douglass HO; Lavin PT; Moertel CG
Cancer Treat Rep; 1976 Jun; 60(6):769-80. PubMed ID: 782699
[TBL] [Abstract][Full Text] [Related]
17. Methyl-CCNU, 6-thioguanine, and 5-fluorouracil in advanced colorectal cancer.
Aroney RS; Dalley DN; Chan WK; Bell DR; Levi JA
Med Pediatr Oncol; 1981; 9(2):181-6. PubMed ID: 7231364
[TBL] [Abstract][Full Text] [Related]
18. Randomized prospective trial comparing 5-fluorouracil (NSC-19893) to 5-fluorouracil and methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer.
Baker LH; Vaitkevicius VK; Gehan E
Cancer Treat Rep; 1976 Jun; 60(6):733-7. PubMed ID: 954013
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial of melphalan plus 5-fluorouracil (5-FU) versus methyl-CCNU plus 5-FU in patients with advanced colorectal cancer.
Berman R; Giles GR; Malhotra A; Bird GG; Gajjar PD; Bunch GA; Hall R
Cancer Treat Rep; 1978 Mar; 62(3):457-9. PubMed ID: 348316
[No Abstract] [Full Text] [Related]
20. Chemotherapy for colorectal cancer with 5-fluorouracil, cyclophosphamide, and CCNU: comparison of oral and continuous iv administration of 5-fluorouracil.
Bedikian AY; Staab R; Livingston R; Valdivieso M; Burgess MA; Bodey GP
Cancer Treat Rep; 1978 Oct; 62(10):1603-5. PubMed ID: 361230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
